Question 1

What is ABOS's ST Score?

Accepted Answer

Acumen Pharmaceuticals, Inc. (ABOS) has an ST Score of 34.9 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Question 2

Is ABOS a buy, hold, or sell?

Accepted Answer

Analysts rate ABOS a Buy, with a price target of $7.00 (+213.2% vs the current price). Our ST Score grades it C- (34.9/100). The ST Score is a data-driven signal, not a recommendation.

Question 3

What are ABOS's factor grades?

Accepted Answer

Valuation B-, Profitability F, Financial Strength D-, Momentum C+, Growth D+, Forecast A.

Question 4

What is ABOS's valuation grade?

Accepted Answer

Acumen Pharmaceuticals, Inc. (ABOS) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

Question 5

What is ABOS's growth grade?

Accepted Answer

Acumen Pharmaceuticals, Inc. (ABOS) earns a growth grade of D+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

Question 6

What is ABOS's profitability grade?

Accepted Answer

Acumen Pharmaceuticals, Inc. (ABOS) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

Question 7

What is ABOS's financial strength grade?

Accepted Answer

Acumen Pharmaceuticals, Inc. (ABOS) earns a financial strength grade of D-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

Question 8

What is the analyst price target for ABOS?

Accepted Answer

The average analyst price target for Acumen Pharmaceuticals, Inc. (ABOS) is $7.00 from 8 analysts, which is +213.2% versus the recent price of $2.23.

Question 9

What is ABOS's Piotroski score?

Accepted Answer

Acumen Pharmaceuticals, Inc. (ABOS) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.

Acumen Pharmaceuticals, Inc. (ABOS) Ownership — Institutional & Insider Holdings

What is institutional ownership of a stock?

How do I check institutional ownership for ABOS?

Is high institutional ownership good for a stock?

What does insider activity tell you about ABOS?

What is the current Acumen Pharmaceuticals, Inc. (ABOS) stock price?

What sector and industry does ABOS operate in?

What is ABOS's market cap?

How many employees does ABOS have?